Morteza Azhdarzadeh

993 total citations
21 papers, 771 citations indexed

About

Morteza Azhdarzadeh is a scholar working on Biomaterials, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Morteza Azhdarzadeh has authored 21 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomaterials, 6 papers in Pharmaceutical Science and 5 papers in Molecular Biology. Recurrent topics in Morteza Azhdarzadeh's work include Nanoparticle-Based Drug Delivery (7 papers), Advanced Drug Delivery Systems (5 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Morteza Azhdarzadeh is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Advanced Drug Delivery Systems (5 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Morteza Azhdarzadeh collaborates with scholars based in Iran, United States and United Kingdom. Morteza Azhdarzadeh's co-authors include Fatemeh Atyabi, Rassoul Dinarvand, Ghobad Mohammadi, Hadi Valizadeh, Farzaneh Lotfipour, Behrang Shiri Varnamkhasti, Morteza Milani, Mohsen Amini, Amir Ata Saei and Saeed Shanehsazzadeh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Pharmaceutics.

In The Last Decade

Morteza Azhdarzadeh

19 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morteza Azhdarzadeh Iran 14 304 264 226 163 149 21 771
Yolandy Lemmer South Africa 12 220 0.7× 169 0.6× 227 1.0× 148 0.9× 91 0.6× 29 712
Somayeh Alimohammadi Iran 11 297 1.0× 189 0.7× 250 1.1× 121 0.7× 130 0.9× 15 724
Huizhu Zhang China 15 199 0.7× 192 0.7× 126 0.6× 100 0.6× 101 0.7× 37 722
Mohamed H. Gaber Egypt 13 417 1.4× 330 1.3× 354 1.6× 90 0.6× 134 0.9× 27 884
Lisa Du Toit South Africa 10 223 0.7× 134 0.5× 215 1.0× 136 0.8× 117 0.8× 20 619
Asuman Bozkır Türkiye 17 330 1.1× 358 1.4× 189 0.8× 312 1.9× 60 0.4× 61 962
Vincenzo De Leo Italy 16 256 0.8× 373 1.4× 176 0.8× 170 1.0× 104 0.7× 38 863
Hossam S. El‐Sawy Egypt 10 441 1.5× 293 1.1× 367 1.6× 239 1.5× 133 0.9× 20 1.0k
Fanfei Meng China 16 259 0.9× 306 1.2× 262 1.2× 131 0.8× 144 1.0× 31 923
Gitu Pandey India 15 194 0.6× 173 0.7× 160 0.7× 130 0.8× 61 0.4× 19 566

Countries citing papers authored by Morteza Azhdarzadeh

Since Specialization
Citations

This map shows the geographic impact of Morteza Azhdarzadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morteza Azhdarzadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morteza Azhdarzadeh more than expected).

Fields of papers citing papers by Morteza Azhdarzadeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morteza Azhdarzadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morteza Azhdarzadeh. The network helps show where Morteza Azhdarzadeh may publish in the future.

Co-authorship network of co-authors of Morteza Azhdarzadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Morteza Azhdarzadeh. A scholar is included among the top collaborators of Morteza Azhdarzadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morteza Azhdarzadeh. Morteza Azhdarzadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Scheinin, Mika, et al.. (2021). A randomized pharmacokinetic-pharmacodynamic evaluation of the potential biosimilar interferon beta-1a product, CinnoVex®. Expert Opinion on Biological Therapy. 22(2). 169–178.
3.
Payandemehr, Pooya, Morteza Azhdarzadeh, Hooman Bahrami‐Motlagh, et al.. (2020). Interferon beta-1a as a Candidate for COVID-19 Treatment; An Open-Label Single-Arm Clinical Trial. SHILAP Revista de lepidopterología. 10 indexed citations
4.
Hajipour, Mohammad Javad, Hossein Mohammad‐Beigi, Iraj Nabipour, et al.. (2020). Amyloid fibril inhibition, acceleration, or fragmentation; Are nano-based approaches advance in the right direction?. Nano Today. 35. 100983–100983. 11 indexed citations
5.
Hassanzadeh, Parichehr, Fatemeh Atyabi, Rassoul Dinarvand, et al.. (2017). Application of nanostructured lipid carriers: the prolonged protective effects for sesamol in in vitro and in vivo models of ischemic stroke via activation of PI3K signalling pathway. DARU Journal of Pharmaceutical Sciences. 25(1). 25–25. 35 indexed citations
6.
Hajipour, Mohammad Javad, Forough Ghasemi, Haniyeh Aghaverdi, et al.. (2017). Sensing of Alzheimer’s Disease and Multiple Sclerosis Using Nano-Bio Interfaces. Journal of Alzheimer s Disease. 59(4). 1187–1202. 33 indexed citations
7.
Azhdarzadeh, Morteza, Fatemeh Atyabi, Amir Ata Saei, et al.. (2016). Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer. Colloids and Surfaces B Biointerfaces. 143. 224–232. 116 indexed citations
8.
Shanehsazzadeh, Saeed, et al.. (2015). External magnetic fields affect the biological impacts of superparamagnetic iron nanoparticles. Colloids and Surfaces B Biointerfaces. 136. 1107–1112. 19 indexed citations
9.
Varnamkhasti, Behrang Shiri, Morteza Azhdarzadeh, Seyed Yaser Vafaei, et al.. (2015). Protein corona hampers targeting potential of MUC1 aptamer functionalized SN-38 core–shell nanoparticles. International Journal of Pharmaceutics. 494(1). 430–444. 84 indexed citations
10.
Azhdarzadeh, Morteza, Amir Ata Saei, Shahriar Sharifi, et al.. (2015). Nanotoxicology: Advances and Pitfalls in Research Methodology. Nanomedicine. 10(18). 2931–2952. 58 indexed citations
11.
Dinarvand, Meshkat, et al.. (2014). MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery. International Journal of Pharmaceutics. 473(1-2). 304–315. 76 indexed citations
12.
Farzadfar, Farshad, Morteza Azhdarzadeh, Haniyeh Aghaverdi, et al.. (2014). Is Amyloid-β an Innocent Bystander and Marker in Alzheimer's Disease? Is the Liability of Multivalent Cation Homeostasis and its Influence on Amyloid-β Function the Real Mechanism?. Journal of Alzheimer s Disease. 42(1). 69–85. 14 indexed citations
13.
Azhdarzadeh, Morteza, et al.. (2013). Serum Multivalent Cationic Pattern: Speculation on the Efficient Approach for Detection of Alzheimer's Disease. Scientific Reports. 3(1). 2782–2782. 17 indexed citations
14.
Talaei, Fatemeh, et al.. (2013). Overcoming therapeutic obstacles in inflammatory bowel diseases: A comprehensive review on novel drug delivery strategies. European Journal of Pharmaceutical Sciences. 49(4). 712–722. 60 indexed citations
15.
Valizadeh, Hadi, et al.. (2012). Antibacterial evaluation of azithromycin nanoparticles. Research in Pharmaceutical Sciences. 7(5). 14. 2 indexed citations
16.
Azhdarzadeh, Morteza, Farzaneh Lotfipour, Parvin Zakeri‐Milani, Ghobad Mohammadi, & Hadi Valizadeh. (2012). Anti-bacterial performance of azithromycin nanoparticles as colloidal drug delivery system against different gram-negative and gram-positive bacteria. SHILAP Revista de lepidopterología. 28 indexed citations
17.
Azhdarzadeh, Morteza, Farzaneh Lotfipour, Parvin Zakeri‐Milani, Ghobad Mohammadi, & Hadi Valizadeh. (2012). Anti-bacterial performance of azithromycin nanoparticles as colloidal drug delivery system against different gram-negative and gram-positive bacteria. PubMed. 2(1). 17–24. 36 indexed citations
18.
Valizadeh, Hadi, Ghobad Mohammadi, Morteza Milani, et al.. (2012). Antibacterial activity of clarithromycin loaded PLGA nanoparticles.. PubMed. 67(1). 63–8. 32 indexed citations
19.
Talaei, Fatemeh, et al.. (2011). Core shell methyl methacrylate chitosan nanoparticles: In vitro mucoadhesion and complement activation.. PubMed. 19(4). 257–65. 8 indexed citations
20.
Mohammadi, Ghobad, Hadi Valizadeh, Mohammad Barzegar-Jalali, et al.. (2010). Development of azithromycin–PLGA nanoparticles: Physicochemical characterization and antibacterial effect against Salmonella typhi. Colloids and Surfaces B Biointerfaces. 80(1). 34–39. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yolandy Lemmer Breakdown of academic impact, for papers by Somayeh Alimohammadi Breakdown of academic impact, for papers by Huizhu Zhang Breakdown of academic impact, for papers by Mohamed H. Gaber Breakdown of academic impact, for papers by Lisa Du Toit Breakdown of academic impact, for papers by Asuman Bozkır Breakdown of academic impact, for papers by Vincenzo De Leo Breakdown of academic impact, for papers by Hossam S. El‐Sawy Breakdown of academic impact, for papers by Fanfei Meng Breakdown of academic impact, for papers by Gitu Pandey
Rankless by CCL
2026